Skip to main content

Eton Pharmaceuticals Inc

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

ETON$56.46+19.7%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Part NoItem NoDescriptionPage No.
IFINANCIAL INFORMATION1
1Financial Statements1
Condensed Balance Sheets as of June 30, 2024 (unaudited) and December 31, 20231
Unaudited Condensed Statements of Operations for the three and six months ended June 30, 2024 and 20232
Unaudited Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2024 and 20233
Unaudited Condensed Statements of Cash Flows for the six months ended June 30, 2024 and 20235
Notes to Condensed Financial Statements6
2Management’s Discussion and Analysis of Financial Condition and Results of Operations22
3Quantitative and Qualitative Disclosures About Market Risk26
4Controls and Procedures27
IIOTHER INFORMATION28
1Legal Proceedings28
1ARisk Factors28
2Unregistered Sales of Equity Securities and Use of Proceeds28
3Defaults Upon Senior Securities28
4Mine Safety Disclosures28
5Other Information28
6Exhibits28
Exhibit Index29
Signatures30

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.